• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Microbiome Times

Pharma & Human Health

Adaptive Phage Therapeutics Announces FDA Clearance of IND Application for PhageBank™ in Treatment of Diabetic Foot Osteomyelitis

March 16, 2021 Microbiome Times

Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to advancing therapies that address the global rise of multi-drug resistant infections, announced today that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug […]

Animal Health

Novozymes acquires data science platform of Biota to strengthen microbiome R&D capabilities in probiotic development

March 12, 2021 Microbiome Times

Novozymes, the world leader in biological solutions, announced the acquisition of the microbiome R&D team and data science platform of Biota. Based in San Diego, US, Biota pioneered industrial genomics using microbiome insights, impacting the […]

Reports

Microbiome Drug Database Update: March 2021

March 4, 2021 Microbiome Times

You must be logged in to view this content. Please login here or if you do not have an account register here.

Pharma & Human Health

Predicting microbial interactions in the human gut

March 4, 2021 Microbiome Times

The human gut consists of a complex community of microbes that consume and secrete hundreds of small molecules–a phenomenon called cross-feeding. However, it is challenging to study these processes experimentally. A new study, published in […]

Finance

Ferring, Rebiotix and MyBiotics Collaborate to Develop Microbiome Therapeutics in Reproductive Medicine and Maternal Health

February 19, 2021 Microbiome Times

Ferring Pharmaceuticals, Rebiotix Inc., a Ferring Company, and MyBiotics Pharma Ltd. today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women of reproductive age […]

Pharma & Human Health

Smectite promotes probiotic biofilm formation in gut for cancer immunotherapy

February 15, 2021 Microbiome Times

Scientists from Nanjing University and the University of Macau have devised a new approach to extend the survival of transplanted probiotics in vivo, enhancing the efficacy of cancer chemo-/immunotherapies in mice. The paper entitled “Smectite […]

Finance

Global biotech executive to boost microbiome drug development for Asia Pacific

February 11, 2021 Microbiome Times

Global biotech executive Thomas Mitchell is set to drive growth, innovation and expansion across Asia Pacific for thriving biotechnology start-up BiomeBank, Australia’s first public stool bank and microbiome therapeutics company, bringing with him a wealth […]

Lallemand Health Solutions

Probiotics to Provide Holistic Health Benefits

February 10, 2021 Microbiome Times

A healthy mind in a healthy body is a widely used mantra, now even more relevant than ever before. Since 2020, consumers’ behavior has evolved: 64% are now more conscious about their immunity and 43% […]

Editor's Choice

Fecal transplant turns cancer immunotherapy non-responders into responders

February 10, 2021 Microbiome Times

Fecal transplant changes the gut microbiome, turning cancer immunotherapy non-responders into responders. Video Credits: UNIVERSITY OF PITTSBURGH   Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut […]

Pharma & Human Health

Investigating the removal of dry biofilm with probiotic cleansers

February 9, 2021 Microbiome Times

A CONCEPT known as dry biofilms has emerged over the past few years and they have shown to frequently harbour potentially infectious organisms, just like the ones present in Hospital Acquired Infections (HAIs). However, as […]

Pharma & Human Health

MIND and Mediterranean diets associated with later onset of Parkinson’s disease

February 5, 2021 Microbiome Times

A new study from UBC researchers suggests a strong correlation between following the MIND and Mediterranean diets and later onset of Parkinson’s disease (PD). While researchers have long known of neuroprotective effects of the MIND […]

Posts navigation

« 1 … 32 33 34 … 76 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
sign up

Sign up to the Microbiome Times newsletter